| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/23/2011 | WO2011036444A4 Heparin cofactor ii fragments with anti-inflammatory and anti-coagulant activity |
| 06/23/2011 | WO2011020090A3 Compositions and methods for treating cancer |
| 06/23/2011 | WO2011020033A3 Engineered proteins including mutant fibronectin domains |
| 06/23/2011 | WO2011019839A3 Glycopeptide and lipoglycopeptide antibiotics with improved solubility |
| 06/23/2011 | WO2011017554A3 Val (8) glp-1 composition and method for treating functional dyspepsia and/or irritable bowel syndrome |
| 06/23/2011 | WO2010144502A9 Growth hormone polypeptides and methods of making and using same |
| 06/23/2011 | WO2010125475A3 Sustained release formulations comprising gnrh analogues |
| 06/23/2011 | WO2009153458A9 Cyclized non-native synthetic peptide and complex of peptides comprising said cyclized peptide, intended to induce and to characterize the prevention or treatment of conditions in mammals |
| 06/23/2011 | US20110154536 Novel Bacillus thuringiensis Gene with Lepidopteran Activity |
| 06/23/2011 | US20110154530 Plants with Increased Yield by Increasing or Generating One or More Activities in a Plant or a Part Thereof |
| 06/23/2011 | US20110154522 BH3 Peptides And Method Of Use Thereof |
| 06/23/2011 | US20110154520 Vitamin K Epoxide Recycling Polypeptide VKORC1, a Therapeutic Target of Coumarin and Their Derivatives |
| 06/23/2011 | US20110152768 Treatment of Solid Tumors with Tissue Inhibitors of Metalloproteinases (TIMPS) |
| 06/23/2011 | US20110152746 Methods for generating new hair follicles, treating baldness, and hair removal |
| 06/23/2011 | US20110152359 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising threreof |
| 06/23/2011 | US20110152203 Transfection agent |
| 06/23/2011 | US20110152202 Development of c-reactive protein mutant with improved therapeutic benefit in immune thrombocytopenia and lupus nephritis |
| 06/23/2011 | US20110152201 Emulsion preconcentrates containing cyclosporin or a macrolide |
| 06/23/2011 | US20110152200 Methods and compositions for inhibition of bcl6 repression |
| 06/23/2011 | US20110152199 Cdca1 peptide and pharmaceutical agent comprising the same |
| 06/23/2011 | US20110152198 Pharmaceutical compositions containing botulinum toxin |
| 06/23/2011 | US20110152197 Analgesic effects of peptide toxin apetx2 |
| 06/23/2011 | US20110152196 Isolated extracellular matrix material including subserous fascia |
| 06/23/2011 | US20110152195 Post irradiation shelf-stable dual paste direct injectable bone cement precursor systems and methods of making same |
| 06/23/2011 | US20110152194 Chimeric natriuretic polypeptides and methods for inhibiting cardiac remodeling |
| 06/23/2011 | US20110152193 Inhibitors of human plasmin derived from the kunitz domains |
| 06/23/2011 | US20110152192 Compositions and Methods for the Treatment of Angiogenesis-Related Eye Diseases |
| 06/23/2011 | US20110152191 Natriuretic polypeptides with unique pharmacologic profiles |
| 06/23/2011 | US20110152190 Erodible polymers for injection |
| 06/23/2011 | US20110152189 Methods for the inhibition of scarring |
| 06/23/2011 | US20110152188 Pharmaceutical compositions of igf/i proteins |
| 06/23/2011 | US20110152187 Insulin-like growth factor fusion proteins |
| 06/23/2011 | US20110152186 Glucagon-like-peptide-2 (glp-2) analogues |
| 06/23/2011 | US20110152185 Pharmaceutical Compositions Comprising GLP-1 Peptides or Extendin-4 and a Basal Insulin Peptide |
| 06/23/2011 | US20110152184 Nutritional Composition for Improving Muscle Function and Daily Activity |
| 06/23/2011 | US20110152183 Derivatised hybrid peptides of amylin and salmon calcitonin |
| 06/23/2011 | US20110152182 Oxyntomodulin peptide analogue |
| 06/23/2011 | US20110152181 Oxyntomodulin peptide analogue |
| 06/23/2011 | US20110152180 Bioactive pentapeptides from rice bran and use thereof |
| 06/23/2011 | US20110152179 Method of treating HIV in drug resistant non plasma viral reservoirs with monomeric DAPTA |
| 06/23/2011 | US20110152178 Prophylactic or therapeutic agent for influenza virus infection |
| 06/23/2011 | US20110152177 Functional Feed Composition |
| 06/23/2011 | US20110152176 Agr-mediated inhibition and dispersal of biofilms |
| 06/23/2011 | US20110152175 Dendrimeric compounds comprising amino acids, hyperbranched core compound, process for preparation of dendrimeric compounds comprising amino acids and hyperbranched core compound, and use thereof |
| 06/23/2011 | US20110152174 Inhibition of secretion from non-neuronal cells |
| 06/23/2011 | US20110152173 TNF-a ANTAGONIST MULTI-TARGET BINDING PROTEINS |
| 06/23/2011 | US20110152172 Methods of Treating Pulmonary Diseases and Disorders by Modulating Calcium/Calmodulin Dependent Protein Kinase II Activity |
| 06/23/2011 | US20110152171 Histamine binding protein |
| 06/23/2011 | US20110152170 Use of Procalcitonin (PCT) in Risk Stratification and Prognosis of Patients with a Primary, Non-Infectious Disease |
| 06/23/2011 | US20110152169 Sparc anti-inflammatory activity and uses thereof |
| 06/23/2011 | US20110152168 Antiadhesive carbohydrates |
| 06/23/2011 | US20110152167 Biodegradable block polymers for drug delivery, and methods related thereto |
| 06/23/2011 | US20110152166 Method of modulation of protein phosphorylation-dependent conformational transitions with low molecular weight compounds |
| 06/23/2011 | US20110151579 Secreted Epithelial Stromal-1 Molecules and Uses Thereof |
| 06/23/2011 | US20110151539 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof |
| 06/23/2011 | US20110151480 Methods of purifying zsig33 |
| 06/23/2011 | US20110151473 Polynucleotides and Polypeptides Encoding Receptors |
| 06/23/2011 | US20110151472 Novel means for the diagnosis and therapy of ctcl |
| 06/23/2011 | US20110151434 Adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| 06/23/2011 | US20110151030 Compositions for alleviating inflammation and oxidative stress in a mammal |
| 06/23/2011 | US20110151028 Topical vaginal preparation |
| 06/23/2011 | US20110151020 Active substance combination with gemcitabine for the treatment of epithelial cancer |
| 06/23/2011 | US20110151016 Use of angiogenin or angiogenin agonists for treating diseases and disorders |
| 06/23/2011 | US20110151007 Carbide-derived-carbon-based oxygen carriers |
| 06/23/2011 | US20110151006 Stimuli-responsive hydrogel |
| 06/23/2011 | US20110150980 Cgrp analog |
| 06/23/2011 | US20110150978 Ph-sensitive block copolymer forming polyionic complex micelles and drug or protein carrier using the same |
| 06/23/2011 | US20110150975 Treatment of Mammalian Physiological Reaction of IgE Antibodies Present in Said Mammal Upon Contact With the Corresponding Antigen |
| 06/23/2011 | US20110150973 Electrospun dextran fibers and devices formed therefrom |
| 06/23/2011 | US20110150943 Adhesive for medical applications and means for haemostasis |
| 06/23/2011 | US20110150938 Supercrystalline Colloidal Particles and Method of Production |
| 06/23/2011 | US20110150920 Allergy Vaccines Containing Hybrid Polypeptides |
| 06/23/2011 | US20110150919 Compositions and methods for the therapy and diagnosis of breast cancer |
| 06/23/2011 | US20110150910 Methods of inducing an immune response |
| 06/23/2011 | US20110150901 Binding proteins that bind to human fgfr1c, human beta-klotho and both human fgfr1c and human beta-klotho |
| 06/23/2011 | US20110150898 EPHA2 as a therapeutic target for cancer |
| 06/23/2011 | US20110150897 Influenza targets |
| 06/23/2011 | US20110150894 Methods of modulating angiogenesis via trpv4 |
| 06/23/2011 | US20110150890 Use of cgrp antagonist compounds for treatment of psoriasis |
| 06/23/2011 | US20110150887 Methods and products relating to gsk3beta regulation |
| 06/23/2011 | US20110150885 Aminoacyl trna synthetases for modulating hematopoiesis |
| 06/23/2011 | US20110150883 Compositions and methods for the therapy and diagnosis of breast cancer |
| 06/23/2011 | US20110150882 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 06/23/2011 | US20110150877 Ephrin-b receptor protein involved in carcinoma |
| 06/23/2011 | US20110150875 Egf-a domain-mediated modulation of pcks9 for treating lipid disorders |
| 06/23/2011 | US20110150872 Soluble heterodimeric cytokine receptor |
| 06/23/2011 | US20110150866 Compositions and Methods for Increasing Bone Mineralization |
| 06/23/2011 | US20110150863 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides |
| 06/23/2011 | US20110150861 Sorf constructs and multiple gene expression |
| 06/23/2011 | US20110150860 Novel 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 and 49933 molecules and uses therefor |
| 06/23/2011 | US20110150859 method for selecting responders to blockade of integrin receptors |
| 06/23/2011 | US20110150858 therapeutic agent for a lower urinary tract disease and an agent for improving a lower urinary tract symptom |
| 06/23/2011 | US20110150856 Compositions and methods for treatment of vitiligo |
| 06/23/2011 | US20110150855 Enzyme Composition and Use Thereof |
| 06/23/2011 | US20110150854 Riboswitches, methods for their use, and compositions for use with riboswitches |
| 06/23/2011 | US20110150849 Tumor-associated Peptides Binding Promiscuously to Human Leukocyte Antigen (HLA) Class II Molecules |
| 06/23/2011 | US20110150841 Secretion System and Methods for its Use |
| 06/23/2011 | US20110150837 Amphiphilic polymer functionalized by methionine |
| 06/23/2011 | US20110150836 Methods of treating hbv and hcv infection |
| 06/23/2011 | US20110150835 Macrocyclic Inhibitors of Hepatitis C Virus NS3 Serine Protease |